Sort
17,054 grants matching “genome editing”
Elucidating the Molecular Role of SYNCRIP in Prostate Cancer and AR Targeted Therapy Resistance
$85,232Ping Mu · Ut Southwestern Medical Center · R37 · FY2023 · CA
Investigating the metal-dependent function, allostery and inhibition of CRISPR-Cas9
$85,191Giulia Palermo · University Of California Riverside · R01 · FY2025 · GM
Sequential ion/ion reactions for large peptide and whole protein characterization
$85,000Joshua J Coon · University Of Wisconsin-Madison · R01 · FY2009 · GM
Administrative Supplement - pHyCCAPP
$84,987Michael Olivier · Wake Forest University Health Sciences · R01 · FY2020 · GM
The olfactory basis of locating nectar sugar sources in Aedes aegypti mosquitoes
$84,979Jeffrey A Riffell · University Of Washington · R01 · FY2024 · AI
Vascular Smooth Muscle Lysyl Oxidase Mediated Increase in Vessel Stiffness and its Effect on Rho-Kinase Mechanosensors: A Novel Mechanism of Atherosclerosis in Chronic Kidney Disease?
$84,941Rajesh Mohandas · University Of Florida · K08 · FY2020 · HL
Gene Therapy for the Treatment of Hereditary Angioedema
$84,750Odelya Edith Pagovich · Weill Medical Coll Of Cornell Univ · R03 · FY2017 · AI
Gene Therapy for the Treatment of Hereditary Angioedema
$84,750Odelya Edith Pagovich · Weill Medical Coll Of Cornell Univ · R03 · FY2016 · AI
Toxoplasma proteins that modulate the host cell
$84,670Jeroen Saeij · Massachusetts Institute Of Technology · R01 · FY2015 · AI
Mitochondrial Protein Import in Trypanosoma brucei
$84,645Minu Chaudhuri · Meharry Medical College · SC1 · FY2009 · GM
Targets of a cytidine deaminase required for left-right axis in Xenopus
$84,500Alin Vonica · Rockefeller University · R03 · FY2009 · HD
Multi-scale modeling of inherited pediatric cardiomyopathies
$84,500Kevin Kit Parker · Harvard University · UH3 · FY2021 · HL
Translating Genetic Risk Factors to Therapies: From Big Data to Druggable Targets
$84,499Benjamin C. Shaw · Cleveland Clinic Lerner Com-Cwru · K00 · FY2022 · NS
Translating Genetic Risk Factors to Therapies: From Big Data to Druggable Targets
$84,499Benjamin C. Shaw · Cleveland Clinic Lerner Com-Cwru · K00 · FY2023 · NS
Translating Genetic Risk Factors to Therapies: From Big Data to Druggable Targets
$84,499Benjamin C. Shaw · Cleveland Clinic Lerner Com-Cwru · K00 · FY2024 · NS
The Role of E2F2 in HER2 Positive Breast Cancer
$84,482Jonathan Rennhack · Dana-Farber Cancer Inst · K00 · FY2019 · CA
Characterizing genetic modifiers in tumor burden of Tuberous Sclerosis Complex
$84,480Robert Mark Vaughan · Michigan State University · K00 · FY2021 · CA
Molecular mechanisms that regulate ADAR target recognition and RNA editing in vivo
$84,444Heather Ann Hundley · Trustees Of Indiana University · R01 · FY2023 · GM
CRISPR/Cas9-Based Functional Characterization of ANK2 Mutations in ASD Neural Circuitry
$84,431Jacob C Garza · Massachusetts General Hospital · K22 · FY2015 · NS
University of Washington Center for Nuclear Organization and Function
$84,366Jay Ashok Shendure · University Of Washington · U54 · FY2019 · DK
Identification of regulators in the vertebrate egg-to-embryo transition
$84,333Cara Moravec · University Of Wisconsin-Madison · K99 · FY2023 · HD
Diversity Supplement -- Vertebrate Photoreceptor Development and Regeneration
$84,232Ann C Morris · University Of Kentucky · R01 · FY2022 · EY
Pilot Project Research Project 2
$84,211Ellen Li · State University New York Stony Brook · P20 · FY2015 · CA
Defining Gene Regulatory Elements Essential to Cancer Cell Viability
$84,162Ryan Adam Rickels · Duke University · K00 · FY2020 · CA
To Combine CRISPR/Cas9 Genome Editing, Nanotech and Chemical Genetics toward in vivo Protein Kinase Analysis
$84,146Degeng Wang · Texas Tech University · R15 · FY2019 · GM